Further studies on adenyl cyclase in psoriasis

Area of Science:

• Dermatology
• Biochemistry
• Enzymology

Background:

• Psoriasis is a chronic inflammatory skin condition.
• The adenyl cyclase system plays a crucial role in cellular signaling.
• Understanding enzyme activity in psoriatic skin is vital for therapeutic development.

Purpose of the Study:

• To investigate adenyl cyclase activity in psoriatic skin plaques compared to normal and uninvolved skin.
• To assess the regulatory mechanisms of adenyl cyclase in response to adrenaline and prostaglandin E2 (PGE2).

Main Methods:

• Human skin samples were obtained and pre-incubated with [3H]adenine to label the ATP pool.
• Radioactive cyclic AMP accumulation was measured to determine adenyl cyclase activity.
• The effects of adrenaline and PGE2 stimulation, along with propranolol blockade, were evaluated.

Main Results:

• Psoriatic plaques exhibited significantly lower [3H]ATP incorporation and adenyl cyclase activity compared to normal and uninvolved skin.
• Adenyl cyclase in psoriatic plaques showed a markedly reduced response (less than five-fold) to adrenaline stimulation versus uninvolved skin (twelve to thirty-two fold).
• Prostaglandin E2 (PGE2) stimulation did not reveal significant differences in adenyl cyclase activity between psoriatic plaques and normal skin.

Conclusions:

• The epidermis in psoriatic plaques possesses a defective adenyl cyclase system, particularly affecting the adrenaline regulatory site.
• Skin adenyl cyclase exhibits distinct regulatory sites for adrenaline and PGE2.
• Uninvolved skin from psoriatic patients demonstrates normal adenyl cyclase activity.